Energy-Based Therapeutics Market by Product Type, Clinical Application, End-User

Description

List of Tables

[182 Pages Report] The Energy-Based Therapeutics Market size was estimated at USD 6.80 billion in 2023 and expected to reach USD 7.28 billion in 2024, at a CAGR 7.36% to reach USD 11.19 billion by 2030.

Global Energy-Based Therapeutics Market

KEY MARKET STATISTICS
Base Year [2023]	USD 6.80 billion
Estimated Year [2024]	USD 7.28 billion
Forecast Year [2030]	USD 11.19 billion
CAGR (%)	7.36%

Energy-based therapeutics refer to a diverse spectrum of medical treatments that utilize various forms of energy to diagnose, manage, or treat medical conditions. The application of these energies aims to bring about physiological changes that can support healing, reduce pain, or alter tissue structures. Energy-based therapeutics encompasses a broad range of modalities, each with unique mechanisms of action and indications. Increasing demand for minimally invasive procedures, higher incidence of cancer cardiovascular diseases, and an increase in cosmetic procedures among the aging population bolster the market's growth. However, a lack of skilled professionals and varied reimbursement policies across different regions can affect the uptake of energy-based procedures. Furthermore, the emergence of home-use energy-based devices and the integration of devices with artificial intelligence can optimize treatment parameters for improved outcomes and patient safety.

Regional Insights

The energy-based therapeutics market in the Americas region is driven by robust healthcare infrastructure, significant R&D investments, and a high adoption rate for innovative medical technologies. Moreover, countries including Brazil and Mexico are gradually incorporating these technologies into their healthcare systems. The pace of adoption varies across different countries due to economic disparities and healthcare infrastructure development. The EMEA region has a well-established healthcare system and significant market potential for energy-based therapeutics. Countries including Germany, the UK, France, and Switzerland are at the forefront of adopting these technologies, with strong research institutions and a favorable regulatory environment. Countries in the Middle East, such as the United Arab Emirates (UAE), Saudi Arabia, and Qatar, are investing in healthcare infrastructure and technology. The Asia Pacific region, particularly China, Japan, and India, is experiencing rapid growth in the energy-based therapeutics market. This growth is propelled by the increasing population, growing medical tourism, advancements in healthcare infrastructure, and rising disposable incomes.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Energy-Based Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Energy-Based Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Energy-Based Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Alna-Medicalsystem AG, AngioDynamics, AtriCure, Inc., BIOLASE, Inc., Biolitec AG, Boston Scientific Corporation, Bovie Medical Corporation, Candela Corporation by Syneron Medical Ltd., Cutera, Inc., Cynosure Inc., Dornier MedTech GmbH, EDAP TMS S.A., Ellex Medical Lasers, InSightec Ltd., IRIDEX Corporation, Johnson and Johnson Vision Care Inc, LightMed Corporation, Lumenis Ltd., Medtronic plc, NIDEk CO. LTD, Optos plc, PhotoMedex, Inc., Symmetry Surgical Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Energy-Based Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Cryotherapy
- Hydro-Mechanical
- Microwave
- Radiofrequency
- Thermal & Ultrasound
Clinical Application
- Aesthetic
- Surgical & Ophthalmic
End-User
- Clinics
- Hospital
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Energy-Based Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Energy-Based Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Energy-Based Therapeutics Market?

4. What is the market share of the leading vendors in the Energy-Based Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Energy-Based Therapeutics Market?

Product Code: MRR-BB4648AFF39C

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Energy-Based Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
  - 5.1.1.2. The surge in popularity of microwave ablation systems over conventional surgeries and treatment
- 5.1.2. Restraints
  - 5.1.2.1. Increasing frequency of product recalls
- 5.1.3. Opportunities
  - 5.1.3.1. Technological innovations and developments in energy-based therapeutics
  - 5.1.3.2. Government initiatives and favorable reimbursement policies for energy-based therapeutics
- 5.1.4. Challenges
  - 5.1.4.1. The dearth of awareness and skilled manpower and therapeutic challenges
5.2. Market Segmentation Analysis
- 5.2.1. Product Type: Growing use of thermal & ultrasound energy-based therapeutics to treat deep-seated lesions
- 5.2.2. Clinical Application: Adoption of energy-based therapeutics in aesthetic application
- 5.2.3. End-User: Emergence of a specialized clinic for energy-based therapeutics
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Energy-Based Therapeutics Market, by Product Type

6.1. Introduction
6.2. Cryotherapy
6.3. Hydro-Mechanical
6.4. Microwave
6.5. Radiofrequency
6.6. Thermal & Ultrasound

7. Energy-Based Therapeutics Market, by Clinical Application

7.1. Introduction
7.2. Aesthetic
7.3. Surgical & Ophthalmic

8. Energy-Based Therapeutics Market, by End-User

8.1. Introduction
8.2. Clinics
8.3. Hospital

9. Americas Energy-Based Therapeutics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Energy-Based Therapeutics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Energy-Based Therapeutics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. New Product Launch & Enhancement
  - 12.3.1.1. Oculus launches IPL, Radiofrequency Therapy Devices
- 12.3.2. Award, Recognition, & Expansion
  - 12.3.2.1. Baird Medical's Microwave Ablation System Gains FDA 510(k) Clearance
  - 12.3.2.2. Emblation Launches Swift Microwave Therapy in the Middle East

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. Alcon Vision LLC
- 13.1.2. Alna-Medicalsystem AG
- 13.1.3. AngioDynamics
- 13.1.4. AtriCure, Inc.
- 13.1.5. BIOLASE, Inc.
- 13.1.6. Biolitec AG
- 13.1.7. Boston Scientific Corporation
- 13.1.8. Bovie Medical Corporation
- 13.1.9. Candela Corporation by Syneron Medical Ltd.
- 13.1.10. Cutera, Inc.
- 13.1.11. Cynosure Inc.
- 13.1.12. Dornier MedTech GmbH
- 13.1.13. EDAP TMS S.A.
- 13.1.14. Ellex Medical Lasers
- 13.1.15. InSightec Ltd.
- 13.1.16. IRIDEX Corporation
- 13.1.17. Johnson and Johnson Vision Care Inc
- 13.1.18. LightMed Corporation
- 13.1.19. Lumenis Ltd.
- 13.1.20. Medtronic plc
- 13.1.21. NIDEk CO. LTD
- 13.1.22. Optos plc
- 13.1.23. PhotoMedex, Inc.
- 13.1.24. Symmetry Surgical Inc.
- 13.1.25. Ziemer Ophthalmic Systems AG
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing